Sirolimus-associated proteinuria and renal dysfunction (Q36674174)

15 August 2017

1 reference

title

Sirolimus-associated proteinuria and renal dysfunction (English)

1 reference

15 August 2017

Gopala K Rangan

1

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

29

1 reference

15 August 2017

12

1 reference

15 August 2017

1153-1161

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200629120-00006

15 August 2017

0 references

cites work

Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200629120-00006

A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis

21 January 2018

1 reference

12 December 2020

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism

1 reference

12 December 2020

Distribution of sirolimus in rat tissue

1 reference

12 December 2020

A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation.

1 reference

12 December 2020

Benefit-risk assessment of sirolimus in renal transplantation

1 reference

12 December 2020

Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function

1 reference

12 December 2020

Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation

1 reference

12 December 2020

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys

1 reference

12 December 2020

Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation

1 reference

12 December 2020

Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms

1 reference

12 December 2020

Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study

1 reference

12 December 2020

Rapamycin: a new string to the antiproteinuric bow?

1 reference

12 December 2020

Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.

1 reference

12 December 2020

Post-transplantation proteinuria and sirolimus

1 reference

12 December 2020

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy

1 reference

12 December 2020

Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data.

1 reference

12 December 2020

Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative

1 reference

12 December 2020

Individualization of immunosuppressive therapy. II. Sirolimus as a less nephrotoxic alternative to calcineurin inhibitors.

1 reference

12 December 2020

Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

1 reference

12 December 2020

Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy

1 reference

12 December 2020

Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.

1 reference

12 December 2020

Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case report

1 reference

12 December 2020

Induction sirolimus and delayed graft function after deceased donor kidney transplantation in the United States

1 reference

12 December 2020

Rapamycin increases transforming growth factor-beta mRNA expression in immortalized rat proximal renal tubular cells

1 reference

12 December 2020

Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury

1 reference

12 December 2020

Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells.

1 reference

12 December 2020

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

1 reference

12 December 2020

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

1 reference

12 December 2020

Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation

1 reference

12 December 2020

Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.

1 reference

12 December 2020

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus

1 reference

12 December 2020

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up

1 reference

12 December 2020

Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study

1 reference

12 December 2020

Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.

1 reference

12 December 2020

Sirolimus lowers myeloperoxidase and p-ANCA titers in a pediatric patient before kidney transplantation

1 reference

12 December 2020

Nephrotoxicity of rapamycin: an emerging problem in clinical medicine

1 reference

12 December 2020

Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience

1 reference

12 December 2020

Is sirolimus responsible for proteinuria?

1 reference

12 December 2020

Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus

1 reference

12 December 2020

Growing roles for the mTOR pathway

1 reference

12 December 2020

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria

1 reference

12 December 2020

Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing

1 reference

12 December 2020

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

1 reference

12 December 2020

Post-transplantation nephrotic syndrome

1 reference

12 December 2020

Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies

1 reference

12 December 2020

Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury

1 reference

12 December 2020

Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway

1 reference

12 December 2020

Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients

1 reference

12 December 2020

Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin

1 reference

12 December 2020

Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks

1 reference

12 December 2020

Sirolimus: its role in nephrology.

1 reference

12 December 2020

Rapamycin at six years can exhibit normal renal function without proteinuria or neoplasia after renal transplantation. A single-center experience

1 reference

12 December 2020

Chronic allograft nephropathy: current concepts and future directions

1 reference

12 December 2020

Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy

1 reference

12 December 2020

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

1 reference

12 December 2020

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

1 reference

12 December 2020

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells

1 reference

12 December 2020

10.2165/00002018-200629120-00006

Identifiers

DOI

1 reference

PubMed ID

17147461

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

17147461